Mass malaria vaccine and drug campaign in Bangladesh villages
Part of Infections clinical trials.
This trial is testing whether giving a malaria vaccine and a malaria drug together to whole villages in Bangladesh can help stop the spread of malaria and protect the entire community. It is open to nearly everyone living in selected villages, including children and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in one of the study villages in Bangladesh.
- You can be any age from 6 months and up (no upper age limit).
- You (or your parent or guardian if you are under 18) must sign a consent form agreeing to join the trial.
- You cannot be pregnant, planning to get pregnant, or breastfeeding.
- You cannot have a serious illness that needs treatment right now.
- You must not have had a bad reaction to similar medicines or vaccines before, and you cannot have already received another malaria vaccine or be in another trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different doses and forms of a malaria vaccine to see which works best and is safest. It may help protect you from malaria for a full year.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
This trial tests if adding a malaria vaccine to seasonal preventive medicines helps protect young children better from malaria. It is for healthy children living in certain areas of Burkina Faso and Mali.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
Hear when a new Plasmodium Falciparum Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.